The brachial plexus injury market size has grown rapidly in recent years. It will grow from $5.1 billion in 2023 to $5.73 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The historic period's growth can be attributed to several factors, including a rise in trauma from road accidents and sports injuries, increased awareness and early diagnosis of brachial plexus injuries, advancements in healthcare infrastructure and accessibility to treatment, a growing elderly population susceptible to neurological conditions, expanded healthcare insurance coverage for complex surgeries, and regulatory approvals for new treatment options.
The brachial plexus injury market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The anticipated growth during the forecast period can be attributed to several factors, an aging population driving higher demand for nerve repair solutions, the use of advanced imaging techniques for precise diagnosis, the adoption of minimally invasive surgical procedures, increased investment in R&D for biologics and tissue engineering, rising healthcare spending in developing economies, and partnerships between medical device companies and research institutions. Key trends for the forecast period include the use of robotic-assisted surgery for accurate nerve reconstruction, expansion of telemedicine and virtual consultations for post-operative care, development of bioresorbable materials for nerve conduits, application of artificial intelligence for personalized treatment plans, growth of outpatient surgical centers for faster recovery, a focus on patient-reported outcomes and quality of life improvements, and a shift towards personalized medicine and customized rehabilitation programs.
An anticipated increase in road accidents is likely to drive the growth of the brachial plexus injury market. Rising vehicle usage and insufficient enforcement of traffic laws exacerbate risks related to speeding and driver negligence, leading to a higher incidence of road accidents. Brachial plexus injury treatment in road accidents often includes surgical procedures, such as nerve grafting or nerve transfer, combined with rehabilitative therapies to restore limb function and mobility. For example, in January 2024, according to a report by The Road Safety Authority, an Ireland-based government agency, revealed that road deaths in 2023 had increased by 19% compared to 2022. This rise in road accidents is consequently boosting the brachial plexus injury market.
Leading companies in the brachial plexus injury market are advancing medical therapies, such as long-acting local analgesics, to improve pain management. These analgesics are crucial for managing pain in brachial plexus injuries, providing prolonged relief through nerve blocks or local infiltration methods, thus enhancing patient comfort, aiding rehabilitation, and reducing the systemic side effects of traditional pain medications. For instance, in March 2021, Pacira BioSciences Inc., a US-based specialty pharmaceutical company, received FDA approval to expand the indications for its non-opioid pain medication, EXPAREL (bupivacaine liposome injectable suspension). This approval included two additional nerve block indications, the Adductor canal block for regional analgesia in lower extremity treatments, and the Sciatic nerve block in the popliteal fossa for lower extremity surgeries. The supplemental new drug application (sNDA) was based on successful Phase 3 studies showing that EXPAREL significantly reduced postsurgical pain and opioid use over 96 hours compared to bupivacaine HCl after procedures such as bunionectomy and total knee arthroplasty.
In January 2024, Catholic Medical Center (CMC), a US-based nonprofit acute-care hospital and regional health system, merged with HCA Healthcare Inc. for an undisclosed amount. This merger is designed to continue and enhance CMC’s health and healing mission, support its operations, and invest in its people and facilities, thereby strengthening regional healthcare delivery in the long term. HCA Healthcare Inc., a US-based healthcare service company, provides treatment for brachial plexus injuries.
Major companies operating in the brachial plexus injury market are Cardinal Health Inc., Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Smith And Nephew plc, Arthrex Inc., Teleflex Incorporated, Karl Storz SE And Co. KG, Cook Medical LLC, Integra LifeSciences Holdings Corporation, CONMED Corporation, DJO Global Inc., LivaNova PLC, MicroPort Scientific Corporation, Wright Medical Group N.V., AngioDynamics Inc., Pentax Medical.
North America was the largest region in the brachial plexus injury market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachial plexus injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the brachial plexus injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A brachial plexus injury refers to damage or trauma to the network of nerves that control movement and sensation in the shoulder, arm, and hand. This type of injury often results from accidents, complications during childbirth, or sports injuries, leading to a range of impairments from mild weakness to complete paralysis. Treatment varies based on the severity of the injury and typically involves a combination of approaches.
The main types of brachial plexus injuries include avulsion, rupture, neurapraxia, axonotmesis, neurotmesis, and neuroma. Avulsion occurs when a nerve is entirely torn away from its attachment to the spinal cord and usually requires complex surgical procedures to restore function. Diagnosis is based on clinical examination, electrodiagnostic tests, and imaging studies, while treatment options such as therapy and surgery address issues related to trauma, inflammation, contact sports, tumors, radiation treatment, and other causes.
The brachial plexus injury market research report is one of a series of new reports that provides brachial plexus injury market statistics, including brachial plexus injury industry global market size, regional shares, competitors with an brachial plexus injury market share, detailed brachial plexus injury market segments, market trends and opportunities, and any further data you may need to thrive in the brachial plexus injury industry. This brachial plexus injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The brachial plexus injury market consists of revenues earned by entities providing services such as surgical interventions, rehabilitation therapies, diagnostic imaging, and long-term care management for individuals affected by brachial plexus injuries. The market value includes the value of related goods sold by the service provider or included within the service offering. The brachial plexus injury market also includes sales of surgical implants, orthotic devices, pain management medications, and diagnostic equipment used for assessing nerve function and injury severity. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The brachial plexus injury market size is expected to see rapid growth in the next few years. It will grow to $9.22 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The anticipated growth during the forecast period can be attributed to several factors, an aging population driving higher demand for nerve repair solutions, the use of advanced imaging techniques for precise diagnosis, the adoption of minimally invasive surgical procedures, increased investment in R&D for biologics and tissue engineering, rising healthcare spending in developing economies, and partnerships between medical device companies and research institutions. Key trends for the forecast period include the use of robotic-assisted surgery for accurate nerve reconstruction, expansion of telemedicine and virtual consultations for post-operative care, development of bioresorbable materials for nerve conduits, application of artificial intelligence for personalized treatment plans, growth of outpatient surgical centers for faster recovery, a focus on patient-reported outcomes and quality of life improvements, and a shift towards personalized medicine and customized rehabilitation programs.
An anticipated increase in road accidents is likely to drive the growth of the brachial plexus injury market. Rising vehicle usage and insufficient enforcement of traffic laws exacerbate risks related to speeding and driver negligence, leading to a higher incidence of road accidents. Brachial plexus injury treatment in road accidents often includes surgical procedures, such as nerve grafting or nerve transfer, combined with rehabilitative therapies to restore limb function and mobility. For example, in January 2024, according to a report by The Road Safety Authority, an Ireland-based government agency, revealed that road deaths in 2023 had increased by 19% compared to 2022. This rise in road accidents is consequently boosting the brachial plexus injury market.
Leading companies in the brachial plexus injury market are advancing medical therapies, such as long-acting local analgesics, to improve pain management. These analgesics are crucial for managing pain in brachial plexus injuries, providing prolonged relief through nerve blocks or local infiltration methods, thus enhancing patient comfort, aiding rehabilitation, and reducing the systemic side effects of traditional pain medications. For instance, in March 2021, Pacira BioSciences Inc., a US-based specialty pharmaceutical company, received FDA approval to expand the indications for its non-opioid pain medication, EXPAREL (bupivacaine liposome injectable suspension). This approval included two additional nerve block indications, the Adductor canal block for regional analgesia in lower extremity treatments, and the Sciatic nerve block in the popliteal fossa for lower extremity surgeries. The supplemental new drug application (sNDA) was based on successful Phase 3 studies showing that EXPAREL significantly reduced postsurgical pain and opioid use over 96 hours compared to bupivacaine HCl after procedures such as bunionectomy and total knee arthroplasty.
In January 2024, Catholic Medical Center (CMC), a US-based nonprofit acute-care hospital and regional health system, merged with HCA Healthcare Inc. for an undisclosed amount. This merger is designed to continue and enhance CMC’s health and healing mission, support its operations, and invest in its people and facilities, thereby strengthening regional healthcare delivery in the long term. HCA Healthcare Inc., a US-based healthcare service company, provides treatment for brachial plexus injuries.
Major companies operating in the brachial plexus injury market are Cardinal Health Inc., Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Terumo Corporation, Smith And Nephew plc, Arthrex Inc., Teleflex Incorporated, Karl Storz SE And Co. KG, Cook Medical LLC, Integra LifeSciences Holdings Corporation, CONMED Corporation, DJO Global Inc., LivaNova PLC, MicroPort Scientific Corporation, Wright Medical Group N.V., AngioDynamics Inc., Pentax Medical.
North America was the largest region in the brachial plexus injury market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brachial plexus injury market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the brachial plexus injury market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A brachial plexus injury refers to damage or trauma to the network of nerves that control movement and sensation in the shoulder, arm, and hand. This type of injury often results from accidents, complications during childbirth, or sports injuries, leading to a range of impairments from mild weakness to complete paralysis. Treatment varies based on the severity of the injury and typically involves a combination of approaches.
The main types of brachial plexus injuries include avulsion, rupture, neurapraxia, axonotmesis, neurotmesis, and neuroma. Avulsion occurs when a nerve is entirely torn away from its attachment to the spinal cord and usually requires complex surgical procedures to restore function. Diagnosis is based on clinical examination, electrodiagnostic tests, and imaging studies, while treatment options such as therapy and surgery address issues related to trauma, inflammation, contact sports, tumors, radiation treatment, and other causes.
The brachial plexus injury market research report is one of a series of new reports that provides brachial plexus injury market statistics, including brachial plexus injury industry global market size, regional shares, competitors with an brachial plexus injury market share, detailed brachial plexus injury market segments, market trends and opportunities, and any further data you may need to thrive in the brachial plexus injury industry. This brachial plexus injury market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The brachial plexus injury market consists of revenues earned by entities providing services such as surgical interventions, rehabilitation therapies, diagnostic imaging, and long-term care management for individuals affected by brachial plexus injuries. The market value includes the value of related goods sold by the service provider or included within the service offering. The brachial plexus injury market also includes sales of surgical implants, orthotic devices, pain management medications, and diagnostic equipment used for assessing nerve function and injury severity. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Brachial Plexus Injury Market Characteristics3. Brachial Plexus Injury Market Trends and Strategies32. Global Brachial Plexus Injury Market Competitive Benchmarking33. Global Brachial Plexus Injury Market Competitive Dashboard34. Key Mergers and Acquisitions in the Brachial Plexus Injury Market
4. Brachial Plexus Injury Market - Macro Economic Scenario
5. Global Brachial Plexus Injury Market Size and Growth
6. Brachial Plexus Injury Market Segmentation
7. Brachial Plexus Injury Market Regional and Country Analysis
8. Asia-Pacific Brachial Plexus Injury Market
9. China Brachial Plexus Injury Market
10. India Brachial Plexus Injury Market
11. Japan Brachial Plexus Injury Market
12. Australia Brachial Plexus Injury Market
13. Indonesia Brachial Plexus Injury Market
14. South Korea Brachial Plexus Injury Market
15. Western Europe Brachial Plexus Injury Market
16. UK Brachial Plexus Injury Market
17. Germany Brachial Plexus Injury Market
18. France Brachial Plexus Injury Market
19. Italy Brachial Plexus Injury Market
20. Spain Brachial Plexus Injury Market
21. Eastern Europe Brachial Plexus Injury Market
22. Russia Brachial Plexus Injury Market
23. North America Brachial Plexus Injury Market
24. USA Brachial Plexus Injury Market
25. Canada Brachial Plexus Injury Market
26. South America Brachial Plexus Injury Market
27. Brazil Brachial Plexus Injury Market
28. Middle East Brachial Plexus Injury Market
29. Africa Brachial Plexus Injury Market
30. Brachial Plexus Injury Market Competitive Landscape and Company Profiles
31. Brachial Plexus Injury Market Other Major and Innovative Companies
35. Brachial Plexus Injury Market Future Outlook and Potential Analysis
36. Appendix
Executive Summary
Brachial Plexus Injury Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on brachial plexus injury market which is experiencing strong growth. the report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for brachial plexus injury? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The brachial plexus injury market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
- the impact of higher inflation in many countries and the resulting spike in interest rates.
- the continued but declining impact of COVID-19 on supply chains and consumption patterns.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Type: Avulsion; Rupture; Neurapraxia; Axonotmesis; Neurotmesis; Neuroma2) by Diagnosis: Clinical Examination; Electrodiagnostic; Imaging Studies
3) by Treatment: Therapy; Surgery
4) by Indication: Trauma; Inflammation; Contact Sports; Tumors; Radiation Treatment; Other Indications
Key Companies Mentioned: Cardinal Health Inc.; Johnson and Johnson; Medtronic plc; Fujifilm Holdings Corporation; Becton Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cardinal Health Inc.
- Johnson And Johnson
- Medtronic plc
- Fujifilm Holdings Corporation
- Becton Dickinson and Company
- Stryker Corporation
- Baxter International Inc.
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Zimmer Biomet Holdings Inc.
- Olympus Corporation
- Terumo Corporation
- Smith And Nephew plc
- Arthrex Inc.
- Teleflex Incorporated
- Karl Storz SE And Co. KG
- Cook Medical LLC
- Integra LifeSciences Holdings Corporation
- CONMED Corporation
- DJO Global Inc.
- LivaNova PLC
- MicroPort Scientific Corporation
- Wright Medical Group N.V.
- AngioDynamics Inc.
- Pentax Medical
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 175 |
Published | September 2024 |
Forecast Period | 2024 - 2028 |
Estimated Market Value ( USD | $ 5.73 Billion |
Forecasted Market Value ( USD | $ 9.22 Billion |
Compound Annual Growth Rate | 12.6% |
Regions Covered | Global |